Unicorn is the exclusive authorized distributor of AstraZeneca in Mauritius and is proud to be associated with this company which brings life changing medicines to patients.
AstraZeneca: pioneer in developing life-changing medicines
AstraZeneca Plc is a global research-based pharmaceutical company, which primarily focuses on the discovery, development and commercialization of prescription medicines for gastrointestinal, cardiovascular, respiratory, oncology and diabetes amongst many diseases.
Diabetes is a disease which affects around 20% of the adult population in Mauritius. On an international level, the number of diabetes is rapidly growing and it is estimated that it will affect more that 592 million people by 2035. AstraZeneca is a pioneer in pushing the boundaries of science and aims at developing life-changing medicines to reduce the complications linked to diabetes. The laboratory has a global clinical research program. AstraZeneca is devoted to having an improved understanding of the treatment effects of their diabetes medicines in broad patient populations, as well as analyzing combination treatments approaches, so that patients have better treatment success. AstraZeneca alims at reducing the long-term impact of diabetes.
Another great area of concern for this laboratory is their research in oncology. Oncology is a branch of research in medicine that is dedicated to the prevention, diagnosis and treatment of cancer. Cancer is a leading cause of death around the world.
AstraZeneca has provided revolutionary cancer medicines for more than 40 years. Many of their medicines have increased the survival rates for patients around the world. Today, AstraZeneca plays an important role in oncology R&D and is dedicated to the progress of science of oncology to bring life-changing medicines to patients.